GB1330805A - Immunization methods against toxic effects of bacterial infection - Google Patents

Immunization methods against toxic effects of bacterial infection

Info

Publication number
GB1330805A
GB1330805A GB1859972A GB1330805DA GB1330805A GB 1330805 A GB1330805 A GB 1330805A GB 1859972 A GB1859972 A GB 1859972A GB 1330805D A GB1330805D A GB 1330805DA GB 1330805 A GB1330805 A GB 1330805A
Authority
GB
United Kingdom
Prior art keywords
elastase
bacterial
toxic effects
bacterial infection
immunization methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1859972A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of GB1330805A publication Critical patent/GB1330805A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1330805 Treatment of bacterial-elastase infection RESEARCH CORP 21 April 1972 18599/72 Heading A5B The toxic effects of infection of a non-human animal by elastase-elaborating bacteria are minimized by parenteral administration of purified bacterial-elastase or immune serum containing antibodies against bacterial-elastase. The bacterial-elastase may be derived from Pseudomonas aeruginosa. The immune serum may be prepared by parenteral administration of bacterial elastase to another animal.
GB1859972A 1972-04-21 1972-04-21 Immunization methods against toxic effects of bacterial infection Expired GB1330805A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1859972 1972-04-21

Publications (1)

Publication Number Publication Date
GB1330805A true GB1330805A (en) 1973-09-19

Family

ID=10115223

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1859972A Expired GB1330805A (en) 1972-04-21 1972-04-21 Immunization methods against toxic effects of bacterial infection

Country Status (1)

Country Link
GB (1) GB1330805A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2575068A1 (en) * 1984-12-24 1986-06-27 Commw Scient Ind Res Org VACCINE FOR PROPHYLAXIS AND FORK TREATMENT, INCLUDING BACTEROID NODOSUS PROTEASE AS ACTIVE SUBSTANCE
WO2003063895A1 (en) * 2002-01-31 2003-08-07 New York University Treatment of bacterial infection with elastase

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2575068A1 (en) * 1984-12-24 1986-06-27 Commw Scient Ind Res Org VACCINE FOR PROPHYLAXIS AND FORK TREATMENT, INCLUDING BACTEROID NODOSUS PROTEASE AS ACTIVE SUBSTANCE
WO2003063895A1 (en) * 2002-01-31 2003-08-07 New York University Treatment of bacterial infection with elastase

Similar Documents

Publication Publication Date Title
ATE7761T1 (en) VACCINE AND PRODUCTION PROCESS.
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
DE3684211D1 (en)
EP0041897A3 (en) Polysaccharide antigen from streptococcus and vaccine containing the same
AU548623B2 (en) Production of antibodies
IT8023226A0 (en) SYSTEM FOR THE INFUSION OF MEDICINES, MAGNETICALLY CONTROLLED.
GB1330805A (en) Immunization methods against toxic effects of bacterial infection
GB1188519A (en) Method for the Purification of Lipopolysaccharides
CA980948A (en) Copolymeres reticules d'acrylonitrile et de monomeres azotes
FR2180594A1 (en) Reducing elastase - elaborating bacterial infection - using bacterial elastase as antigen
EP0327648A4 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient.
IE32044L (en) Tetanus vaccine
GB1338459A (en) Flavanone derivatives and process for inhibiting growth of microorganisms using such compounds
CA972682A (en) Immunization methods against toxic effects of bacterial infection
FR2499855B1 (en) NOVEL CARCINOSTATIC AND IMMUNO-STIMULATING SUBSTANCES, PROCESS FOR PREPARING SAME FROM FUSOBACTERIUM BACTERIA, AND CARCINOSTATIC AGENT CONTAINING SUCH SUBSTANCES
CH449045A (en) Process for the preparation of amino acids or their esters, the amino or imino group of which is protected by the t-amyloxycarbonyl group
AU3649071A (en) The preparation of 3'-deoxykanamycin active against resistant bacteria
GB1254948A (en) Antivirial substance
SE389875B (en) METHOD OF PRODUCING ALMOST EXCLUSIVELY RIFAMYCIN B BY CULTIVATION OF STREPTO - MYCES MEDITERRANEAL M 18 ATCC 21789 IN THE ABSENCE OF DIETHYL BARBITIC ACID AND ITS ANALOGES
OA04275A (en) New antibiotic, its preparation by culturing a streptomyces and compositions containing it.
CA962380A (en) Procede et dispositif d'asservissement en position des faisceaux d'ions dans les spectometres de masse
CA879658A (en) Compositions containing a benzoxazolone derivative for the treatment or prevention of parasitic infections in domestic animals
CA914593A (en) Procede perfectionne de culture d'algues
CA997532A (en) Prevention of microbial growth by treatment with hypochlorous acid
DK462281A (en) PROCEDURE FOR THE PREPARATION OF ANTIBIOTICS S / 433

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee